Outpatient follow-up during the first year after heart transplantation, is it feasible?

详细信息    查看全文

• 作者：Ana Ayesta ; MD ; PhD^a ; ¹ ; Iago Sousa-Casasnovas ; MD^a ; ¹ ; Edwin Gó ; mez ; MD^a ; ¹ ; Manuel Martí ; nez-Sellé ; s ; MD ; PhD^a ; ^b ; ^c ; ¹ ; ^{mmselles@secardiologia.es} ; Francisco Ferná ; ndez-Avilé ; s ; MD ; PhD^a ; ^b ; ¹
• 关键词：Heart transplantation ; Follow-up ; Day hospital ; Outpatient
• 刊名：International Journal of Cardiology
• 出版年：2017
• 出版时间：1 February 2017
• 年：2017
• 卷：228
• 期：Complete
• 页码：1-3
• 全文大小：187 K
• 卷排序：228

文摘

First year follow-up after heart transplantation requires invasive tests. Although patients used to be hospitalized for this purpose, ambulatory invasive procedures now offer the possibility of outpatient follow-up. The feasibility and security of this strategy is unknown.MethodsFrom 2007 we transitioned to outpatient follow-up. We have retrospectively reviewed the clinical course of the outpatient group (2007 to 2014) and an inpatient group (2000–2006). Basal characteristics, hospital stay, infections, rejection episodes and vascular complications were evaluated.Results87 patients had Inpatient Follow-up (IF) and 98 Outpatient Follow-up (OF). Basal characteristics were similar, with significant differences in immunosuppression (tacrolimus IF 44.8% vs. OF 90.8%, and mycophenolate IF 86.2% vs OF 100%, both p values < 0.001) and age (IF 52 ± 11.5 years vs. OF 56.1 ± 11 years, p = 0.016). In the OF group more clinical visits were performed (IF 10 vs. OF 13, p < 0.001) while hospital stay was lower (IF 23 days vs. OF 3 days, p < 0.001). The rate of infection, rejection, and vascular complications was similar. No difference was found in 1-year mortality (IF 2.3% vs. 1.0%, p = 0.60).ConclusionFirst year post-cardiac transplantation outpatient follow-up seems to be feasible and safe in terms of infection, rejection, vascular complications and mortality.